Stock 300529 JAFRON BIOMEDICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
28.54 CNY -1.48% Intraday chart for Jafron Biomedical Co.,Ltd. -1.92% +28.39%
Apr. 26 Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 CI
Apr. 25 Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 30,077 54,196 42,653 24,741 17,755 22,103 - -
Enterprise Value (EV) 1 30,077 54,196 42,653 24,741 17,755 22,103 22,103 22,103
P/E ratio 52.8 x 62.8 x 35.8 x 27.4 x 39 x 28.1 x 21.9 x 16.6 x
Yield - 0.97% - - - - - -
Capitalization / Revenue 21 x 27.8 x 15.9 x 9.93 x 9.24 x 7.66 x 5.98 x 4.8 x
EV / Revenue 21 x 27.8 x 15.9 x 9.93 x 9.24 x 7.66 x 5.98 x 4.8 x
EV / EBITDA 42.3 x 54 x 29 x 22.7 x 27.2 x 21.4 x 16.1 x 12.5 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 14 x 19.3 x 13.3 x 7.24 x 5.93 x 6 x 5.11 x 4.31 x
Nbr of stocks (in thousands) 795,460 799,109 800,245 798,864 798,709 774,466 - -
Reference price 2 37.81 67.82 53.30 30.97 22.23 28.54 28.54 28.54
Announcement Date 2/5/20 3/31/21 4/11/22 3/30/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,432 1,951 2,675 2,491 1,922 2,884 3,697 4,601
EBITDA 1 711.1 1,003 1,472 1,089 652.5 1,033 1,372 1,763
EBIT 1 680.3 1,054 1,418 1,029 543.8 991 1,310 1,677
Operating Margin 47.52% 54.05% 53% 41.32% 28.29% 34.36% 35.43% 36.46%
Earnings before Tax (EBT) 1 671.3 1,032 1,407 1,017 521 972.8 1,290 1,658
Net income 1 570.8 875.2 1,197 889.5 436.5 818.8 1,054 1,391
Net margin 39.87% 44.87% 44.73% 35.7% 22.71% 28.39% 28.5% 30.24%
EPS 2 0.7158 1.080 1.490 1.130 0.5700 1.015 1.305 1.723
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - 0.6600 - - - - - -
Announcement Date 2/5/20 3/31/21 4/11/22 3/30/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3
Net sales 1 572.6 439.6 473.8
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Dividend per Share - - -
Announcement Date 4/27/23 8/18/23 10/27/23
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 30.2% 35.7% 38.1% 26.3% 13.1% 22.1% 25% 27.2%
ROA (Net income/ Total Assets) - 30.6% - - - 12.8% 13.6% 14.6%
Assets 1 - 2,856 - - - 6,396 7,748 9,530
Book Value Per Share 2 2.690 3.510 4.020 4.280 3.750 4.760 5.580 6.620
Cash Flow per Share 2 0.7300 1.200 1.550 1.090 1.140 0.8800 1.290 1.630
Capex 1 - 356 536 469 235 344 331 294
Capex / Sales - 18.26% 20.05% 18.82% 12.21% 11.93% 8.96% 6.39%
Announcement Date 2/5/20 3/31/21 4/11/22 3/30/23 4/25/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Jafron Biomedical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
28.54 CNY
Average target price
33.94 CNY
Spread / Average Target
+18.94%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
JAFRON BIOMEDICAL CO.,LTD. Stock Jafron Biomedical Co.,Ltd.
+28.39% 3.05B
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.77% 182B
MEDTRONIC PLC Stock Medtronic plc
+4.10% 114B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.85% 67.76B
DEXCOM, INC. Stock DexCom, Inc.
+5.19% 51.91B
CENCORA, INC. Stock Cencora, Inc.
+5.54% 43.23B
HOYA CORPORATION Stock Hoya Corporation
+6.07% 41.07B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+23.81% 32.07B
TERUMO CORPORATION Stock Terumo Corporation
+15.86% 25B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.06% 24.35B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 300529 Stock
  4. Financials Jafron Biomedical Co.,Ltd.